Pazopanib treatment for primary cardiovascular sarcoma: A retrospective observational study and literature review.
- DOI
- 10.3892/ol.2026.15829
- Published
- 2026 Oct
- Container
- Oncology letters
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3892/ol.2026.15829,
title = {Pazopanib treatment for primary cardiovascular sarcoma: A retrospective observational study and literature review.},
author = {Yamanaka S and Yakushijin Y and Hasebe S and Yamamoto S and Fujii T and Kitazawa R and Fujibuchi T and Kidani T and Maruta M},
year = {2026},
journal = {Oncology letters},
doi = {10.3892/ol.2026.15829},
url = {https://doi.org/10.3892/ol.2026.15829}
}RIS
TY - JOUR TI - Pazopanib treatment for primary cardiovascular sarcoma: A retrospective observational study and literature review. AU - Yamanaka S AU - Yakushijin Y AU - Hasebe S AU - Yamamoto S AU - Fujii T AU - Kitazawa R AU - Fujibuchi T AU - Kidani T AU - Maruta M PY - 2026 JO - Oncology letters DO - 10.3892/ol.2026.15829 UR - https://doi.org/10.3892/ol.2026.15829 ER -
APA
S, Y., Y, Y., S, H., S, Y., T, F., R, K., T, F., T, K., & M, M. (2026). Pazopanib treatment for primary cardiovascular sarcoma: A retrospective observational study and literature review.. Oncology letters. https://doi.org/10.3892/ol.2026.15829
Source records
- pubmed · retrieved 2026-09-25T18:07:40.193Z